Skip to main content

David B. Bayne, MD, MPH

Image
Dr. David Bayne

David B. Bayne, MD, MPH

Assistant Professor of Urology
Director of Global Education and Simulation
Chief of Urology, Zuckerberg San Francisco General Hospital and Trauma Center

Education

  • BA, 2006 Harvard College, Biochemistry, Spanish Minor
  • MD, 2012 Harvard Medical School, Medicine
  • MPH, 2017 University of California, Berkeley, Health Policy and Management
  • Residency, 2018 University of California, San Francisco, Urology
  • Fellowship, 2020 University of California, San Francisco, Endourology

Biography

Dr. David Bayne, MD, MPH has built his career as a physician-scientist dedicated to improving access and outcomes in surgical care, particularly for patients with urinary stone disease (USD). He received his undergraduate degree in Biochemistry from Harvard College and earned his medical degree at Harvard Medical School in 2012. He completed his urology residency at the University of California, San Francisco (UCSF), during which he also earned a Master of Public Health from the University of California, Berkeley, to strengthen his skills in health disparities research. Following residency, he continued at UCSF as a Fellow in Endourology and Laparoscopy under the mentorship of Drs. Marshall Stoller and Thomas Chi. In 2020, Dr. Bayne joined the UCSF Department of Urology faculty, where he now serves as an Assistant Professor.

Clinical Interests

Dr. Bayne’s clinical practice focuses on urinary stone disease, ureteral strictures, and minimally invasive surgical management of complex urologic conditions. He specializes in endoscopic, laparoscopic, and percutaneous approaches, including both fluoroscopic and ultrasound-guided kidney access, robotic and laparoscopic reconstruction, and Holmium Laser Enucleation of the Prostate (HoLEP). He continues to be engaged in global surgical outreach and collaborations aimed at strengthening urologic training and care delivery in resource-limited settings.

Research Interests

Dr. Bayne’s research integrates clinical outcomes, epidemiology, and health equity to address disparities in urinary stone disease care. During residency and fellowship, he led studies demonstrating independent associations between lower socioeconomic status and delayed presentation for USD treatment. As a UCSF faculty member, his early work was supported by the UCSF–Kaiser UroEpi K12 award, enabling large-scale analyses that linked structural barriers to care with the need for more invasive surgical interventions and poorer outcomes.

Dr. Bayne currently holds a K23 Career Development Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through which he is developing targeted interventions to reduce care delays in USD. To date, he has authored multiple peer‑reviewed publications, including several as first or senior author, consistently demonstrating that timely, equitable access to surgical care can markedly improve outcomes for patients with stone disease.

More information:

Patient Contact

Note that UCSF Urology utilizes an online system for scheduling appointments called MyChart. This is our preferred method of communications. If you are not yet signed up for MyChart, call 415.514.6000 to get an activation code and help signing up.

 

400 Parnassus Ave. 
6th Floor Urology Clinic
A610, Box 0330
San Francisco, CA 94143-0330
Fax: 415.353.2480 or 415.353.2641

Academic Contact

400 Parnassus Ave,
6th Floor Urology Clinic
 A610,
Box 0330

San Francisco, CA 94143-0330

Fax: 415.353.2480 or 415.353.2641

Send Email